| Keyword search (4,163 papers available) | ![]() |
"neuroinflamation" Keyword-tagged Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women | Gagne C; Piot A; Brake WG; | 35115970 CSBN |
| Title: | Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women | ||||
| Authors: | Gagne C, Piot A, Brake WG | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/35115970/ | ||||
| DOI: | 10.3389/fpsyt.2021.797577 | ||||
| Publication: | Frontiers in psychiatry | ||||
| Keywords: | estradiol (17ß; -estradiol); glutamate; microglia; neuroinflamation; sex differences; | ||||
| PMID: | 35115970 | Category: | Date Added: | 2022-02-04 | |
| Dept Affiliation: |
CSBN
1 Department of Psychology, Centre for Studies in Behavioural Neurobiology Concordia University, Montreal, QC, Canada. |
||||
Description: |
Ketamine has been shown to acutely and rapidly ameliorate depression symptoms and suicidality. Given that women suffer from major depression at twice the rate of men, it is important to understand how ketamine works in the female brain. This review explores three themes. First, it examines our current understanding of the etiology of depression in women. Second, it examines preclinical research on ketamine's antidepressant effects at a neurobiological level as well as how ovarian hormones present a unique challenge in interpreting these findings. Lastly, the neuroinflammatory hypothesis of depression is highlighted to help better understand how ovarian hormones might interact with ketamine in the female brain. |



